JP2015536947A5 - - Google Patents

Download PDF

Info

Publication number
JP2015536947A5
JP2015536947A5 JP2015540764A JP2015540764A JP2015536947A5 JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5 JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound according
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536947A (ja
JP6482466B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067673 external-priority patent/WO2014070978A1/en
Publication of JP2015536947A publication Critical patent/JP2015536947A/ja
Publication of JP2015536947A5 publication Critical patent/JP2015536947A5/ja
Application granted granted Critical
Publication of JP6482466B2 publication Critical patent/JP6482466B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540764A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6482466B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722151P 2012-11-03 2012-11-03
US61/722,151 2012-11-03
PCT/US2013/067673 WO2014070978A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2015536947A JP2015536947A (ja) 2015-12-24
JP2015536947A5 true JP2015536947A5 (enExample) 2016-12-15
JP6482466B2 JP6482466B2 (ja) 2019-03-13

Family

ID=49620280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540764A Active JP6482466B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9284310B2 (enExample)
EP (1) EP2914591B1 (enExample)
JP (1) JP6482466B2 (enExample)
WO (1) WO2014070978A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10118904B2 (en) 2015-06-05 2018-11-06 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of Demyelinating Diseases
ES2953467T3 (es) 2016-04-15 2023-11-13 Elanco Animal Health Gmbh Derivados de pirazolopirimidina
JP2021505652A (ja) * 2017-12-04 2021-02-18 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 3−アミノ−[1,2,4]−トリアゾール誘導体および望ましくない植物成長を制御するためのその使用
CN108003062B (zh) * 2017-12-25 2020-08-11 常州吉恩药业有限公司 一种单boc保护双氨基化合物的合成方法
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
AR118243A1 (es) 2019-03-07 2021-09-22 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
AR119140A1 (es) 2019-06-13 2021-11-24 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
JP7573289B2 (ja) * 2019-06-25 2024-10-25 マイクロバイオティックス, インク. フィロシクロビルによる眼感染症を治療または予防するための組成物および方法
WO2021033141A1 (en) 2019-08-20 2021-02-25 Pi Industries Ltd. Fused heterocyclic compounds and their use as pest control agents
TW202535873A (zh) 2019-09-26 2025-09-16 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物
AR121344A1 (es) 2020-02-18 2022-05-11 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes para el control de plagas
TW202334117A (zh) 2020-08-24 2023-09-01 美商達薩瑪治療公司 Sarm1之抑制劑
WO2022208370A1 (en) 2021-03-31 2022-10-06 Pi Industries Ltd. Fused heterocyclic compounds and their use as pest control agents
WO2025177310A1 (en) 2024-02-23 2025-08-28 Pi Industries Ltd. Fused heterocyclic compounds and its uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
KR20010086091A (ko) * 1998-12-09 2001-09-07 이곤 이 버그 치환된 페닐렌디아민 그룹을 함유하는 허프스 바이러스의헤테로사이클릭 카복사미드-함유 티오우레아 억제제
JP2002531554A (ja) * 1998-12-09 2002-09-24 ワイス フェニレンジアミン群を含む、複素環式カルボキサミド含有の、ヘルペスウイルスのチオ尿素インヒビター
AU1934500A (en) * 1998-12-09 2000-06-26 Wyeth Thiourea inhibitors of herpes viruses
HUP0303813A3 (en) 2001-04-19 2005-05-30 Bayer Ag Arylsulfonamides as antiviral agents, process for preparation of the compounds and pharmaceutical compositions containing them
CA2506772A1 (en) 2002-11-01 2004-05-21 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of jak and other protein kinases
SE0203654D0 (sv) * 2002-12-09 2002-12-09 Astrazeneca Ab New compounds
EP1594512A4 (en) 2003-02-11 2007-07-11 Kemia Inc COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
US20090196912A1 (en) 2004-07-30 2009-08-06 Gpc Botech Ag Pyridinylamines
EP1896461A2 (en) 2005-06-30 2008-03-12 Amgen Inc. Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
US20090069288A1 (en) * 2007-07-16 2009-03-12 Breinlinger Eric C Novel therapeutic compounds
WO2010029300A1 (en) 2008-09-12 2010-03-18 Biolipox Ab Bis aromatic compounds for use in the treatment of inflammation
EP2177521A1 (en) 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2379075A4 (en) 2008-12-16 2012-05-30 Merck Sharp & Dohme TRIAZOL DERIVATIVES FOR THE TREATMENT OF ALZHEIMER DISEASE
US20130109682A1 (en) 2010-07-06 2013-05-02 Novartis Ag Cyclic ether compounds useful as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2015536947A5 (enExample)
JP2016503403A5 (enExample)
JP2014520767A5 (enExample)
JP2019501125A5 (enExample)
JP2013544860A5 (enExample)
JP2016505614A5 (enExample)
JP2015500843A5 (enExample)
JP2016530259A5 (enExample)
JP2018533593A5 (enExample)
JP2016516043A5 (enExample)
JP2012092103A5 (enExample)
JP2017508782A5 (enExample)
JP2013523614A5 (enExample)
JP2014508811A5 (enExample)
JP2017501237A5 (enExample)
JP2015504081A5 (enExample)
JP2013537203A5 (enExample)
JP2012506389A5 (enExample)
JP2016503052A5 (enExample)
JP2015537008A5 (enExample)
JP2014526533A5 (enExample)
JP2015522650A5 (enExample)
JP2017517565A5 (enExample)
JP2015500842A5 (enExample)
JP2014500296A5 (enExample)